Expert's Opinion

The Objective is to Be Objective

Steering toward more reliable data in dermatology clinical trials

Darcee Duke Strube 03.05.18

Can Everybody Stop Using Net Promoter Score Already?

Don't buy into hype, buy into science.

03.02.18

Five Digital Trends Transforming the Life Sciences Industry

Putting patients at the heart of innovation

12.05.17

Analyzing Developments in the CAR-T Field

A detailed look at opportunities and limitations of current T-cell therapies

Dr. John Savin, B.Sc, Ph.D., MBA, analyst at Edison Investment Research Ltd. 11.13.17

Leveraging EHR Data to Support Clinical Trials

Technology now exists to free up EHR data and streamline the clinical trial process

Dr. Manfred Stapff, Chief Medical Officer, TriNetX 11.06.17

Fill/Finish | Lyophilization

Primary Containment Trends in Lyophilization

Plastic caps for aseptic crimping can reduce unwanted interactions

Sylvia Marzotko, Senior Manager Product Management, West 10.25.17

APIs

Biocatalysis for APIs

Engineered enzymes pave easier, faster road to scalable API manufacturing

Michael Aldridge, SVP of Corporate and Strategic Development, Codexis 09.12.17

Evolution of the CRO Project Manager

As clinical project managers become more strategic, more advanced technology must support their evolving roles

Andy Mehrotra, CEO, EightSpokes 08.31.17

CRO Competition Heats Up: Differentiate Offerings to Retain Site Loyalty

Site centricity becomes even more critical with increased CRO competition and M&A

Dave Espenshade, Vice President of CRO Partnerships, Greenphire 07.25.17

The Analytical Challenges of the Biosimilar Boom

The growing biosimilar industry and its implications on the current drug market

Mario DiPaola, Senior Scientific Director, Charles River Laboratories 07.03.17

Differentiating in the Biosimilar Market: Surviving the Cost of Entry

Companies need to improve customer experience, produce additional evidence, and create valuable engagement with stakeholders

Michael Turner and Magnus Franzen, Life Sciences Experts, PA Consulting Group 06.19.17

When Big Data is Not Enough

Leveraging real-world data and advanced analytics to develop more targeted recruiting strategies for rare diseases

Adina Knight , Medical Director and Medical Strategy Lead at QuintilesIMS 06.16.17

Bio News

Know the Challenges of Biosimilar Manufacturing

Best Practices for a Competitive Market

Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 06.12.17

Opportunity Knocks for Inhalers in Emerging Markets

As key drugs and delivery devices come off-patent emerging markets offer potential for inhaled generics

Dr. Anselm Ebert, Global Business Development Manager, H&T Presspart 06.05.17

Solving the Pharma Talent Crunch

Addressing talent shortages in today's pharmaceutical sector

Jim Sykes, Managing Director, Pharmaceutical & Life Sciences, Alexander Mann Solutions 05.30.17

Regulatory Affairs

Using Pragmatic Randomization in Real-World Studies

How PCTs increase the robustness of real world studies at a fraction of the cost of classic randomized trials

Nancy Dreyer, MPH, Ph.D. , Global Chief of Scientific Affairs and Senior Vice President, Real-World & Late Phase Research, QuintilesIMS 05.22.17

Breaking New Ground: How Industry Collaboration is Transforming Clinical Research

An increasingly complex clinical trial landscape drives the life sciences industry to support broad collaborations

Jill Johnston, Vice President, Veeva Vault, Veeva Systems 05.15.17

Can In Vitro Testing Replace Human Clinical Trials for Topical Drugs?

The future of topical bioequivalence studies

Theo Kapanadze, Chief Scientific Officer, Diteba 05.08.17

Aseptic Processing | cGMP Manufacture | Facilities | Fill/Finish

Innovative Manufacturing Technology for Aseptic Filling

V-CRT: Combining quality and OEE advantages

Gerald Buerkle, Vice President Production, Vetter Pharma-Fertigung GmbH & Co. KG 04.20.17